CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 102 filers reported holding CHEMOCENTRYX INC in Q3 2019. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $419,000 | -41.3% | 45,000 | -12.5% | 0.01% | -35.7% |
| Q1 2019 | $714,000 | +35.5% | 51,400 | +6.4% | 0.01% | +27.3% |
| Q4 2018 | $527,000 | -21.5% | 48,300 | -9.0% | 0.01% | -8.3% |
| Q3 2018 | $671,000 | -10.5% | 53,100 | -6.7% | 0.01% | -7.7% |
| Q2 2018 | $750,000 | -30.2% | 56,900 | -28.0% | 0.01% | -31.6% |
| Q1 2018 | $1,075,000 | +134.7% | 79,000 | +2.5% | 0.02% | +137.5% |
| Q4 2017 | $458,000 | +23.5% | 77,100 | +54.2% | 0.01% | -11.1% |
| Q3 2017 | $371,000 | -4.9% | 50,000 | +20.2% | 0.01% | 0.0% |
| Q2 2017 | $390,000 | – | 41,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |